Clinical Trials Browser

Phase 3 × tocilizumab × 30 days × Clear all

NCT05171647 2026-03-06

SUNMO

Phase 3 Active not recruiting

208 enrolled 12 charts

Lymphoma, Non-Hodgkin

NCT06084936 2026-03-03

GLOBRYTE

Phase 3 Recruiting

Lymphoma